The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants. / Behrendt, N; Rønne, E; Ploug, M; Petri, T.; Løber, D.; Nielsen, Lars S; Schleuning, W.D.; Blasi, F.; Appella, E; Danø, K.

I: The Journal of Biological Chemistry, Bind 265, Nr. 11, 15.04.1990, s. 6453-60.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Behrendt, N, Rønne, E, Ploug, M, Petri, T, Løber, D, Nielsen, LS, Schleuning, WD, Blasi, F, Appella, E & Danø, K 1990, 'The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants', The Journal of Biological Chemistry, bind 265, nr. 11, s. 6453-60.

APA

Behrendt, N., Rønne, E., Ploug, M., Petri, T., Løber, D., Nielsen, L. S., Schleuning, W. D., Blasi, F., Appella, E., & Danø, K. (1990). The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants. The Journal of Biological Chemistry, 265(11), 6453-60.

Vancouver

Behrendt N, Rønne E, Ploug M, Petri T, Løber D, Nielsen LS o.a. The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants. The Journal of Biological Chemistry. 1990 apr. 15;265(11):6453-60.

Author

Behrendt, N ; Rønne, E ; Ploug, M ; Petri, T. ; Løber, D. ; Nielsen, Lars S ; Schleuning, W.D. ; Blasi, F. ; Appella, E ; Danø, K. / The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants. I: The Journal of Biological Chemistry. 1990 ; Bind 265, Nr. 11. s. 6453-60.

Bibtex

@article{420a0d53c0fd4bd7bdf7e7824941cf71,
title = "The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants",
abstract = "The receptor for human urokinase-type plasminogen activator (u-PA) was purified from phorbol 12-myristate 13-acetate-stimulated U937 cells by temperature-induced phase separation of detergent extracts, followed by affinity chromatography with immobilized diisopropyl fluorophosphate-treated u-PA. The purified protein shows a single 55-60 kDa band after sodium dodecyl sulfate-polyacrylamide gel electrophoresis and silver staining. It is a heavily glycosylated protein, the deglycosylated polypeptide chain comprising only 35 kDa. The glycosylated protein contains N-acetyl-D-glucosamine and sialic acid, but no N-acetyl-D-galactosamine. Glycosylation is responsible for substantial heterogeneity in the receptor on phorbol ester-stimulated U937 cells, and also for molecular weight variations among various cell lines. The amino acid composition and the NH2-terminal amino acid sequence are reported. The protein has a high content of cysteine residues. The NH2-terminal sequence is not closely related to any known sequence. The identification of the purified and sequenced protein with the human u-PA receptor is based on the following findings: 1) the ability of the purified protein to bind u-PA and its amino-terminal fragment; 2) the identical electrophoretic mobilities observed for cross-linked conjugates, formed between either the purified protein or the u-PA receptor on intact U937 cells and the above ligands; 3) the identity of the apparent molecular weight of the purified protein to that predicted for the u-PA receptor in the same cross-linking studies; 4) the identical extent of glycosylation of the purified protein and of the u-PA receptor in crude membrane fractions, as detected after cross-linking; 5) the ability of antibodies raised against the purified protein to inhibit cellular binding of the amino-terminal fragment of u-PA.",
keywords = "Amino Acid Sequence, Amino Acids, Cell Line, Chromatography, Affinity, Electrophoresis, Polyacrylamide Gel, Enzyme Precursors, Genetic Variation, Glycosylation, Humans, Molecular Sequence Data, Molecular Weight, Receptors, Cell Surface, Receptors, Urokinase Plasminogen Activator, Tetradecanoylphorbol Acetate, Urokinase-Type Plasminogen Activator, Journal Article, Research Support, Non-U.S. Gov't",
author = "N Behrendt and E R{\o}nne and M Ploug and T. Petri and D. L{\o}ber and Nielsen, {Lars S} and W.D. Schleuning and F. Blasi and E Appella and K Dan{\o}",
year = "1990",
month = apr,
day = "15",
language = "English",
volume = "265",
pages = "6453--60",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology, Inc.",
number = "11",

}

RIS

TY - JOUR

T1 - The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants

AU - Behrendt, N

AU - Rønne, E

AU - Ploug, M

AU - Petri, T.

AU - Løber, D.

AU - Nielsen, Lars S

AU - Schleuning, W.D.

AU - Blasi, F.

AU - Appella, E

AU - Danø, K

PY - 1990/4/15

Y1 - 1990/4/15

N2 - The receptor for human urokinase-type plasminogen activator (u-PA) was purified from phorbol 12-myristate 13-acetate-stimulated U937 cells by temperature-induced phase separation of detergent extracts, followed by affinity chromatography with immobilized diisopropyl fluorophosphate-treated u-PA. The purified protein shows a single 55-60 kDa band after sodium dodecyl sulfate-polyacrylamide gel electrophoresis and silver staining. It is a heavily glycosylated protein, the deglycosylated polypeptide chain comprising only 35 kDa. The glycosylated protein contains N-acetyl-D-glucosamine and sialic acid, but no N-acetyl-D-galactosamine. Glycosylation is responsible for substantial heterogeneity in the receptor on phorbol ester-stimulated U937 cells, and also for molecular weight variations among various cell lines. The amino acid composition and the NH2-terminal amino acid sequence are reported. The protein has a high content of cysteine residues. The NH2-terminal sequence is not closely related to any known sequence. The identification of the purified and sequenced protein with the human u-PA receptor is based on the following findings: 1) the ability of the purified protein to bind u-PA and its amino-terminal fragment; 2) the identical electrophoretic mobilities observed for cross-linked conjugates, formed between either the purified protein or the u-PA receptor on intact U937 cells and the above ligands; 3) the identity of the apparent molecular weight of the purified protein to that predicted for the u-PA receptor in the same cross-linking studies; 4) the identical extent of glycosylation of the purified protein and of the u-PA receptor in crude membrane fractions, as detected after cross-linking; 5) the ability of antibodies raised against the purified protein to inhibit cellular binding of the amino-terminal fragment of u-PA.

AB - The receptor for human urokinase-type plasminogen activator (u-PA) was purified from phorbol 12-myristate 13-acetate-stimulated U937 cells by temperature-induced phase separation of detergent extracts, followed by affinity chromatography with immobilized diisopropyl fluorophosphate-treated u-PA. The purified protein shows a single 55-60 kDa band after sodium dodecyl sulfate-polyacrylamide gel electrophoresis and silver staining. It is a heavily glycosylated protein, the deglycosylated polypeptide chain comprising only 35 kDa. The glycosylated protein contains N-acetyl-D-glucosamine and sialic acid, but no N-acetyl-D-galactosamine. Glycosylation is responsible for substantial heterogeneity in the receptor on phorbol ester-stimulated U937 cells, and also for molecular weight variations among various cell lines. The amino acid composition and the NH2-terminal amino acid sequence are reported. The protein has a high content of cysteine residues. The NH2-terminal sequence is not closely related to any known sequence. The identification of the purified and sequenced protein with the human u-PA receptor is based on the following findings: 1) the ability of the purified protein to bind u-PA and its amino-terminal fragment; 2) the identical electrophoretic mobilities observed for cross-linked conjugates, formed between either the purified protein or the u-PA receptor on intact U937 cells and the above ligands; 3) the identity of the apparent molecular weight of the purified protein to that predicted for the u-PA receptor in the same cross-linking studies; 4) the identical extent of glycosylation of the purified protein and of the u-PA receptor in crude membrane fractions, as detected after cross-linking; 5) the ability of antibodies raised against the purified protein to inhibit cellular binding of the amino-terminal fragment of u-PA.

KW - Amino Acid Sequence

KW - Amino Acids

KW - Cell Line

KW - Chromatography, Affinity

KW - Electrophoresis, Polyacrylamide Gel

KW - Enzyme Precursors

KW - Genetic Variation

KW - Glycosylation

KW - Humans

KW - Molecular Sequence Data

KW - Molecular Weight

KW - Receptors, Cell Surface

KW - Receptors, Urokinase Plasminogen Activator

KW - Tetradecanoylphorbol Acetate

KW - Urokinase-Type Plasminogen Activator

KW - Journal Article

KW - Research Support, Non-U.S. Gov't

M3 - Journal article

C2 - 2156852

VL - 265

SP - 6453

EP - 6460

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 11

ER -

ID: 178214871